These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37991759)

  • 1. Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening.
    Knudsen AB; Trentham-Dietz A; Kim JJ; Mandelblatt JS; Meza R; Zauber AG; Castle PE; Feuer EJ
    JAMA Netw Open; 2023 Nov; 6(11):e2344698. PubMed ID: 37991759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
    Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
    JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
    Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
    JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force.
    Kim JJ; Burger EA; Regan C; Sy S
    JAMA; 2018 Aug; 320(7):706-714. PubMed ID: 30140882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
    Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing Breast, Cervical, and Colorectal Cancer Deaths: Assessing the Impact of Increased Screening.
    Sharma KP; Grosse SD; Maciosek MV; Joseph D; Roy K; Richardson LC; Jaffe H
    Prev Chronic Dis; 2020 Oct; 17():E123. PubMed ID: 33034556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018.
    Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R
    JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force.
    Knudsen AB; Rutter CM; Peterse EFP; Lietz AP; Seguin CL; Meester RGS; Perdue LA; Lin JS; Siegel RL; Doria-Rose VP; Feuer EJ; Zauber AG; Kuntz KM; Lansdorp-Vogelaar I
    JAMA; 2021 May; 325(19):1998-2011. PubMed ID: 34003219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
    Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
    JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.
    Knudsen AB; Zauber AG; Rutter CM; Naber SK; Doria-Rose VP; Pabiniak C; Johanson C; Fischer SE; Lansdorp-Vogelaar I; Kuntz KM
    JAMA; 2016 Jun; 315(23):2595-609. PubMed ID: 27305518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Curry SJ; Krist AH; Owens DK; Barry MJ; Caughey AB; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Kubik M; Landefeld CS; Mangione CM; Phipps MG; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2018 Aug; 320(7):674-686. PubMed ID: 30140884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Davidson KW; Barry MJ; Mangione CM; Cabana M; Caughey AB; Davis EM; Donahue KE; Doubeni CA; Krist AH; Kubik M; Li L; Ogedegbe G; Owens DK; Pbert L; Silverstein M; Stevermer J; Tseng CW; Wong JB
    JAMA; 2021 May; 325(19):1965-1977. PubMed ID: 34003218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Joint Lung Cancer Screening and Cessation Interventions Under the New Recommendations of the U.S. Preventive Services Task Force.
    Meza R; Cao P; Jeon J; Taylor KL; Mandelblatt JS; Feuer EJ; Lowy DR
    J Thorac Oncol; 2022 Jan; 17(1):160-166. PubMed ID: 34648947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
    Trentham-Dietz A; Chapman CH; Jayasekera J; Lowry KP; Heckman-Stoddard BM; Hampton JM; Caswell-Jin JL; Gangnon RE; Lu Y; Huang H; Stein S; Sun L; Gil Quessep EJ; Yang Y; Lu Y; Song J; Muñoz DF; Li Y; Kurian AW; Kerlikowske K; O'Meara ES; Sprague BL; Tosteson ANA; Feuer EJ; Berry D; Plevritis SK; Huang X; de Koning HJ; van Ravesteyn NT; Lee SJ; Alagoz O; Schechter CB; Stout NK; Miglioretti DL; Mandelblatt JS
    JAMA; 2024 Jun; 331(22):1947-1960. PubMed ID: 38687505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers.
    Amboree TL; Montealegre JR; Parker SL; Garg A; Damgacioglu H; Schmeler KM; Chiao EY; Hill EG; Sonawane K; Deshmukh AA; Adsul P
    JAMA Intern Med; 2024 Jun; 184(6):671-679. PubMed ID: 38683574
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.